26525840|t|Pax6 influences expression patterns of genes involved in neuro- degeneration.
26525840|a|BACKGROUND: Pax6, a highly conserved multifunctional transcription factor, has been critical for neurogenesis and neuronal plasticity. It is presumed that if level of Pax6 approaches either low or null, critical genes responsible for maintaining functional status of neurons or glia would be modulated. PURPOSE: Therefore, it has been intended to explore possibility of either direct or indirect influence of Pax6 in neurodegeneration. METHODS: The cell lines having origin of murine embryonic fibroblast (Pax6-non expressing, NIH3T3-cell line), murine neuroblastoma (Pax6-expressing brain-derived, Neuro-2a-cell line), and human glioblastoma-astrocytoma (U87MG) were cultured and maintained in a CO2 incubator at 37 C and 5% CO2 in DMEM containing 10% fetal bovine serum. The knockdown of endogenous Pax6 in Neuro-2a cells was achieved through siRNA based gene knock-down approach. The efficiency and validation of knock-down was done by real time PCR. The knock-down of Pax6 was successfully achieved. RESULTS: The levels of expression of transcripts of some of the proposed putative markers of neurodegeneration like Pax6, S100beta, GFAP, BDNF, NGN2, p73alpha, p73delta, LDH, SOD, and Catalase were analyzed in Pax6 knockdown condition for analysis of role of Pax6 in neurodegeneration. Since the Pax6 has been proposed to bind to promoter sequences of catalase, and catalase suppresses TGFbeta, relative lower levels of catalase in Neuro-2a and U-87MG as compared to NIH-3T3 indicates a possible progressive dominant negative impact of Pax6. However, presence of SOD and LDH indicates alternative protective mechanism. CONCLUSION: Presence of BDNF and TGFbeta indicates association between them in glioblastoma-astrocytoma. Therefore, Pax6 seems to be involved directly with p53 and TGFbeta mediated pathways and indirectly with redox-sensitive pathway regulation. The neurodegenerative markers S100beta, GFAP, BDNF, NGN2, p73alpha, p73delta, observed downregulated in Pax6 knockdown condition suggest Pax6-mediated regulation of these markers. Observations enlighten Pax6-mediated influences on cascades of genes involved in growth, differentiation and maturation of neurons and glia.
26525840	0	4	Pax6	Gene	18508
26525840	57	76	neuro- degeneration	Disease	MESH:D009410
26525840	90	94	Pax6	Gene	18508
26525840	245	249	Pax6	Gene	18508
26525840	487	491	Pax6	Gene	18508
26525840	495	512	neurodegeneration	Disease	MESH:D019636
26525840	555	561	murine	Species	10090
26525840	584	588	Pax6	Gene	18508
26525840	605	611	NIH3T3	CellLine	CVCL:0594
26525840	624	630	murine	Species	10090
26525840	646	650	Pax6	Gene	18508
26525840	677	685	Neuro-2a	CellLine	CVCL:0470
26525840	702	707	human	Species	9606
26525840	708	732	glioblastoma-astrocytoma	Disease	MESH:D005909
26525840	734	739	U87MG	CellLine	CVCL:0022
26525840	775	778	CO2	Chemical	MESH:D002245
26525840	804	807	CO2	Chemical	MESH:D002245
26525840	811	815	DMEM	Chemical	-
26525840	879	883	Pax6	Gene	18508
26525840	887	895	Neuro-2a	CellLine	CVCL:0470
26525840	1050	1054	Pax6	Gene	18508
26525840	1175	1192	neurodegeneration	Disease	MESH:D019636
26525840	1198	1202	Pax6	Gene	18508
26525840	1204	1212	S100beta	Gene	20203
26525840	1214	1218	GFAP	Gene	14580
26525840	1220	1224	BDNF	Gene	12064
26525840	1226	1230	NGN2	Gene	11924
26525840	1257	1260	SOD	Gene	6647
26525840	1266	1274	Catalase	Gene	12359
26525840	1292	1296	Pax6	Gene	18508
26525840	1341	1345	Pax6	Gene	18508
26525840	1349	1366	neurodegeneration	Disease	MESH:D019636
26525840	1378	1382	Pax6	Gene	5080
26525840	1434	1442	catalase	Gene	847
26525840	1448	1456	catalase	Gene	847
26525840	1468	1475	TGFbeta	Gene	7040
26525840	1502	1510	catalase	Gene	847
26525840	1514	1522	Neuro-2a	CellLine	CVCL:0470
26525840	1527	1533	U-87MG	CellLine	CVCL:0022
26525840	1549	1556	NIH-3T3	CellLine	CVCL:0594
26525840	1618	1622	Pax6	Gene	18508
26525840	1645	1648	SOD	Gene	6647
26525840	1725	1729	BDNF	Gene	627
26525840	1734	1741	TGFbeta	Gene	7040
26525840	1780	1804	glioblastoma-astrocytoma	Disease	MESH:D005909
26525840	1817	1821	Pax6	Gene	5080
26525840	1857	1860	p53	Gene	22060
26525840	1865	1872	TGFbeta	Gene	21803
26525840	1951	1968	neurodegenerative	Disease	MESH:D019636
26525840	1977	1985	S100beta	Gene	20203
26525840	1987	1991	GFAP	Gene	14580
26525840	1993	1997	BDNF	Gene	12064
26525840	1999	2003	NGN2	Gene	11924
26525840	2051	2055	Pax6	Gene	18508
26525840	2084	2088	Pax6	Gene	18508
26525840	2150	2154	Pax6	Gene	18508
26525840	Association	21803	5080
26525840	Association	MESH:D019636	18508
26525840	Association	627	7040
26525840	Association	18508	6647
26525840	Positive_Correlation	12064	18508
26525840	Association	5080	847
26525840	Association	MESH:D019636	11924
26525840	Association	18508	22060
26525840	Positive_Correlation	12359	18508
26525840	Association	MESH:D019636	20203
26525840	Association	MESH:D019636	12064
26525840	Association	14580	18508
26525840	Negative_Correlation	18508	847
26525840	Association	MESH:D019636	12359
26525840	Positive_Correlation	18508	20203
26525840	Association	MESH:D019636	6647
26525840	Positive_Correlation	11924	18508
26525840	Negative_Correlation	7040	847
26525840	Association	MESH:D009410	18508
26525840	Association	MESH:D005909	7040
26525840	Association	MESH:D019636	14580
26525840	Association	MESH:D005909	627
26525840	Association	22060	5080
26525840	Association	18508	21803

